Evolution of Active Surveillance of Prostate Cancer: Impact of MRI, MRI-guided Biopsy and Focal Therapy

Genitourinary Cancer

Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatment

BJU Int

de Vos II, Marenghi C, Badenchini F, Boevé ER, Lozano-Uruñuela F, Graefen M, Rannikko AS, Staerman F, Sugimoto M, Kato T, Somford DM, Frydenberg M, Bangma CH, Remmers S, Roobol MJ, Prostate Cancer Research International: Active Surveillance (PRIAS) consortium

doi: 10.1111/bju.16727

Genitourinary Cancer

Does a Negative Prostate Biopsy Reduce the Risk of Prostate Cancer Reclassification in an Active Surveillance Protocol? An Updated Systematic Review and Meta-Analysis

Prostate

Bahri RA, Mohammadi A, Yar EZ, Rezayat M, Heshmat R, Aghamir SMK

doi: 10.1002/pros.24851

Genitourinary Cancer

Focal therapy using high-intensity focused ultrasound with intraoperative prostate compression for patients with localized prostate cancer: a multi-center prospective study with 7 year experience

Prostate Cancer Prostatic Dis

Shoji S, Naruse J, Ohno S, Aoki M, Takahashi K, Yuzuriha S, Kuroda S, Umemoto T, Nakajima N, Hasegawa M, Kawamura Y, Kajiwara H, Hashida K, Uemura K, Hasebe T, Tajiri T

doi: 10.1038/s41391-024-00921-0

Genitourinary Cancer

Targeted Biopsy is Sufficient for Men on Active Surveillance for Early-Stage Prostate Cancer

J Urol

Fakunle MO, Cowan JE, Washington SL 3rd, Shinohara K, Nguyen HG, Carroll PR

doi: 10.1097/JU.0000000000004265

Genitourinary Cancer

Comparative Evaluation of Detection Rates for Clinically Significant Prostate Cancer Using MRI-Targeted Biopsy Alone Versus in Combination With Systematic Biopsies: Development of a Risk-Stratification Scoring System

Prostate

Takahashi T, Nakashima M, Maruno K, Hazama T, Yamada Y, Kikkawa K, Umeoka S, Tamaki M, Ito N

doi: 10.1002/pros.24821

Genitourinary Cancer

VISION: An Individual Patient Data Meta-analysis of Randomised Trials Comparing Magnetic Resonance Imaging Targeted Biopsy with Standard Transrectal Ultrasound Guided Biopsy in the Detection of Prostate Cancer

Eur Urol

Kasivisvanathan V, Wai-Shun Chan V, Clement KD, Levis B, Ng A, Asif A, Haider MA, Emberton M, Pond GR, Agarwal R, Scandrett K, Takwoingi Y, Klotz L, Moore CM, VISION Study Collaborators

doi: 10.1016/j.eururo.2024.08.022

Genitourinary Cancer

Long-term Outcomes and Prognostic Impact of Residual Cancer Burden After Intensified Neoadjuvant Therapy in High-risk Prostate Cancer

Eur Urol

Ravi P, Kwak L, Acosta AM, Rastogi S, Xie W, Abdelnaser A, Einstein DJ, Chang P, Wagner AA, McKay RR, Kibel AS, Taplin ME

doi: 10.1016/j.eururo.2025.01.015

Genitourinary Cancer

Polygenic Risk Score and Upgrading in Patients With Prostate Cancer Receiving Active Surveillance

JAMA Oncol

Goss LB, Liu M, Zheng Y, Guo B, Conti DV, Haiman CA, Kachuri L, Catalona WJ, Witte JS, Lin DW, Newcomb LF, Darst BF

doi: 10.1001/jamaoncol.2024.5398

Genitourinary Cancer

Oncological Safety of MRI-Informed Biopsy Decision-Making in Men With Suspected Prostate Cancer

JAMA Oncol

Hamm CA, Asbach P, Pöhlmann A, Schoots IG, Kasivisvanathan V, Henkel TO, Johannsen M, Speck T, Baur ADJ, Haas M, Collettini F, Penzkofer T, Savic LJ, Konietschke F, Weißbach L, Hamm B, König F, Cash H

doi: 10.1001/jamaoncol.2024.5497

Related content

Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatment

Does a Negative Prostate Biopsy Reduce the Risk of Prostate Cancer Reclassification in an Active Surveillance Protocol? An Updated Systematic Review and Meta-Analysis

Focal therapy using high-intensity focused ultrasound with intraoperative prostate compression for patients with localized prostate cancer: a multi-center prospective study with 7 year experience

Targeted Biopsy is Sufficient for Men on Active Surveillance for Early-Stage Prostate Cancer

Comparative Evaluation of Detection Rates for Clinically Significant Prostate Cancer Using MRI-Targeted Biopsy Alone Versus in Combination With Systematic Biopsies: Development of a Risk-Stratification Scoring System

VISION: An Individual Patient Data Meta-analysis of Randomised Trials Comparing Magnetic Resonance Imaging Targeted Biopsy with Standard Transrectal Ultrasound Guided Biopsy in the Detection of Prostate Cancer

Long-term Outcomes and Prognostic Impact of Residual Cancer Burden After Intensified Neoadjuvant Therapy in High-risk Prostate Cancer

Polygenic Risk Score and Upgrading in Patients With Prostate Cancer Receiving Active Surveillance

Oncological Safety of MRI-Informed Biopsy Decision-Making in Men With Suspected Prostate Cancer